The Oncosearch | Oncotarget

Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer Priority Research Paper

Agnieszka K. Witkiewicz, Nicholas A. Borja, Jorge Franco, Jonathan R. Brody, Charles J. Yeo, John Mansour, Michael A. Choti, Peter McCue, Erik S. Knudsen

Published Apr 14, 2015 · Vol. 6, No. 18 · pp. 15788-15801

PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy Research Paper

FranÃ§ois Bertucci, Pascal Finetti, CÃ©cile Colpaert, Emilie Mamessier, Maxime Parizel, Luc Dirix, Patrice Viens, Daniel Birnbaum, Steven Van Laere

Published Apr 11, 2015 · Vol. 6, No. 15 · pp. 13506-13519

The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs Research Paper

Yanna Tang, Wenfeng Fang, Yaxiong Zhang, Shaodong Hong, Shiyang Kang, Yue Yan, Nan Chen, Jianhua Zhan, Xiaobo He, Tao Qin, Ge Li, Wenyi Tang, Peijian Peng, Li Zhang

Published Mar 29, 2015 · Vol. 6, No. 16 · pp. 14209-14219

An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma Clinical Research Papers

Qian Mei, Meixia Chen, Xuechun Lu, Xiang Li, Feng Duan, Maoqiang Wang, Guangbin Luo, Weidong Han

Published Mar 29, 2015 · Vol. 6, No. 18 · pp. 16698-16711

Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets Research Paper

Sujana Movva, Wenhsiang Wen, Wangjuh Chen, Sherri Z. Millis, Zoran Gatalica, Sandeep Reddy, Margaret von Mehren, Brian A. Van Tine

Published Mar 26, 2015 · Vol. 6, No. 14 · pp. 12234-12247

microRNA-4717 differentially interacts with its polymorphic target in the PD1 3â€™ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases Research Paper

Guoyu Zhang, Na Li, Zhu Li, Qianqian Zhu, Fang Li, Cuiling Yang, Qunying Han, Yi Lv, Zhihua Zhou, Zhengwen Liu

Published Mar 26, 2015 · Vol. 6, No. 22 · pp. 18933-18944

Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation Clinical Research Papers

Andreas D. Ã˜rskov, Marianne B. Treppendahl, Anni Skovbo, Mette S. Holm, Lone S. Friis, Marianne Hokland, Kirsten GrÃ¸nbÃ¦k

Published Mar 18, 2015 · Vol. 6, No. 11 · pp. 9612-9626

Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma Research Paper

Yong Feng, Jacson Shen, Yan Gao, Yunfei Liao, Gregory Cote, Edwin Choy, Ivan Chebib, Henry Mankin, Francis Hornicek, Zhenfeng Duan

Published Mar 14, 2015 · Vol. 6, No. 13 · pp. 11139-11149

PD-1 pathway inhibitors: The next generation of immunotherapy for advanced melanoma Review

Jason J. Luke, Patrick A. Ott

Published Feb 17, 2015 · Vol. 6, No. 6 · pp. 3479-3492

Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients Research Paper

Maria Napolitano, Crescenzo D'Alterio, Eleonora Cardone, Anna Maria Trotta, Biagio Pecori, Daniela Rega, Ugo Pace, Dario Scala, GiosuÃ¨ Scognamiglio, Fabiana Tatangelo, Carmela Cacciapuoti, Roberto Pacelli, Paolo Delrio, Stefania Scala

Published Jan 21, 2015 · Vol. 6, No. 10 · pp. 8261-8270

Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma Research Paper

Ziming Du, Malak Abedalthagafi, Ayal A. Aizer, Allison R. McHenry, Heather H. Sun, Mark-Anthony Bray, Omar Viramontes, Revaz Machaidze, Priscilla K. Brastianos, David A. Reardon, Ian F. Dunn, Gordon J. Freeman, Keith L. Ligon, Anne E. Carpenter, Brian M. Alexander, Nathalie Y. Agar, Scott J. Rodig, Elizabeth M. Bradshaw, Sandro Santagata

Published Dec 31, 2014 · Vol. 6, No. 7 · pp. 4704-4716

Prognostic and predictive value of PDL1 expression in breast cancer Clinical Research Papers

Renaud Sabatier, Pascal Finetti, Emilie Mamessier, JosÃ© Adelaide, Max Chaffanet, Hamid Raza Ali, Patrice Viens, Carlos Caldas, Daniel Birnbaum, FranÃ§ois Bertucci

Published Dec 31, 2014 · Vol. 6, No. 7 · pp. 5449-5464

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer Research Paper

Jennifer L. Bishop, Alexander Sio, Arkhjamil Angeles, Morgan E. Roberts, Arun A. Azad, Kim N. Chi, Amina Zoubeidi

Published Nov 6, 2014 · Vol. 6, No. 1 · pp. 234-242

EBV-driven LMP1 and IFN-Î³ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy Research Paper

Wenfeng Fang, Jianwei Zhang, Shaodong Hong, Jianhua Zhan, Nan Chen, Tao Qin, Yanna Tang, Yaxiong Zhang, Shiyang Kang, Ting Zhou, Xuan Wu, Wenhua Liang, Zhihuang Hu, Yuxiang Ma, Yuanyuan Zhao, Ying Tian, Yunpeng Yang, Cong Xue, Yue Yan, Xue Hou, Peiyu Huang, Yan Huang, Hongyun Zhao, Li Zhang

Published Oct 21, 2014 · Vol. 5, No. 23 · pp. 12189-12202

Intratumoral administration of mRNA encoding a fusokine consisting of IFN-Î² and the ectodomain of the TGF-Î² receptor II potentiates antitumor immunity Research Paper

Kevin Van der Jeught, Patrick Tjok Joe, Lukasz Bialkowski, Carlo Heirman, Lidia Daszkiewicz, Therese Liechtenstein, David Escors, Kris Thielemans, Karine Breckpot

Published Sep 19, 2014 · Vol. 5, No. 20 · pp. 10100-10113

An updated overview of HPV-associated head and neck carcinomas Review

Apostolos Zaravinos

Published May 1, 2014 · Vol. 5, No. 12 · pp. 3956-3969

Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity Research Paper

Adrienne L. Watson, Bryant J. Keller, Kyle A. Williams, Namrata N. Damle, Samuel J. Finnerty, Leah K. Anderson, Andrew D. Greeley, Vincent W. Keng, Eric P. Rahrmann, Amanda L. Halfond, Natasha M. Powell, Margaret H. Collins, Tilat Rizvi, Christopher L. Moertel, Nancy Ratner, David A. Largaespada

Published Jan 20, 2014 · Vol. 5, No. 6 · pp. 1502-1514

Keywords: Malignant peripheral nerve sheath tumors, plexiform neurofibromas, Schwann cells, neurofibromatosis type 1 syndrome, neurofibromin 1, PI3K/AKT/mTOR signaling, MAPK signaling, targeted therapies, genetically engineered mouse models, combination therapy

Alterations of immune response of non-small cell lung cancer with Azacytidine Research Paper

John Wrangle, Wei Wang, Alexander Koch, Hariharan Easwaran, Helai P. Mohammad, Xiaoyu Pan, Frank Vendetti, Wim VanCriekinge, Tim DeMeyer, Zhengzong Du, Princy Parsana, Kristen Rodgers, Ray-Whay Yen, Cynthia A. Zahnow, Janis M. Taube, Julie R. Brahmer, Scott S. Tykodi, Keith Easton, Richard D. Carvajal, Peter A. Jones, Peter W. Laird, Daniel J. Weisenberger, Salina Tsai, Rosalyn A. Juergens, Suzanne L. Topalian, Charles M. Rudin, Malcolm V. Brock, Drew Pardoll, Stephen B. Baylin

Published Oct 25, 2013 · Vol. 4, No. 11 · pp. 2067-2079

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer Priority Research Paper

PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy Research Paper

The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs Research Paper

An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma Clinical Research Papers

Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets Research Paper

microRNA-4717 differentially interacts with its polymorphic target in the PD1 3â€™ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases Research Paper

Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation Clinical Research Papers

Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma Research Paper

PD-1 pathway inhibitors: The next generation of immunotherapy for advanced melanoma Review

Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients Research Paper

Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma Research Paper

Prognostic and predictive value of PDL1 expression in breast cancer Clinical Research Papers

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer Research Paper

EBV-driven LMP1 and IFN-Î³ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy Research Paper

Intratumoral administration of mRNA encoding a fusokine consisting of IFN-Î² and the ectodomain of the TGF-Î² receptor II potentiates antitumor immunity Research Paper

An updated overview of HPV-associated head and neck carcinomas Review

Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity Research Paper

Alterations of immune response of non-small cell lung cancer with Azacytidine Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer Priority Research Paper

PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy Research Paper

The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs Research Paper

An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma Clinical Research Papers

Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets Research Paper

microRNA-4717 differentially interacts with its polymorphic target in the PD1 3â€™ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases Research Paper

Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation Clinical Research Papers

Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma Research Paper

PD-1 pathway inhibitors: The next generation of immunotherapy for advanced melanoma Review

Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients Research Paper

Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma Research Paper

Prognostic and predictive value of PDL1 expression in breast cancer Clinical Research Papers

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer Research Paper

EBV-driven LMP1 and IFN-Î³ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy Research Paper

Intratumoral administration of mRNA encoding a fusokine consisting of IFN-Î² and the ectodomain of the TGF-Î² receptor II potentiates antitumor immunity Research Paper

An updated overview of HPV-associated head and neck carcinomas Review

Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity Research Paper

Alterations of immune response of non-small cell lung cancer with Azacytidine Research Paper